Earnings Releases·Nov 9, 2026, 4:05 PM ET

Paysign — Third Quarter 2026 Earnings Summary

Q3 2026 revenue reached $30.80 million, up 42.6% year-over-year, while GAAP net income surged 204.1% to $6.74 million and Adjusted EBITDA rose 118.0% to $10.98 million.
The company raised full-year 2026 guidance for Gross Profit Margin, Net Income, GAAP Diluted EPS, and Adjusted EBITDA, confirming revenue expectations of $114.0 million to $117.0 million.
Patient affordability revenue grew 109.8% to $16.62 million, offsetting a 1.0% decline in gross dollar load volume and a 7.5% increase in plasma revenue despite a loss of 33 centers.
Management confirmed confidence in exceeding prior profitability outlooks, though a customer transition of 113 plasma centers is expected to reduce Q4 revenue by $1.5 million and gross profit by $700,000.
The balance sheet remains strong with $34.54 million in unrestricted cash, zero bank debt, and total assets of $347.47 million, supporting continued investment in a pending software platform.